Latest scientific publications

  • Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.

  • Auteurs Ogbogu PU, Roufosse F, Akuthota P, Kuna P, Groh M, Reiter A, Yokota A, Siddiqui SH, Mutsaers PGNJ, Li B, Khoury P, Bahadori LM, Bednarczyk A, Bouma G, Brooks LG, Ferreira J, Grindebacke H, Ho CN, Jain P, Palmer RL, Jison ML, Klion AD
  • Revue Nat Med
  • Date de publication 2026-05
Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial.
  • ChatGPT, Gemini, and Claude in clinical and dermoscopic image analysis of basal cell carcinoma and its common mimickers: A comparative performance analysis.

  • Auteurs Boostani M, Zouboulis CC, Pellacani G, Navarrete-Dechent C, Boussingault L, Kiss T, Goldfarb N, Cantisani C, Nádudvari N, Bánvölgyi A, Wikonkál NM, Suppa M, Paragh G, Kiss N
  • Revue JID Innov
  • Date de publication 2026-05
ChatGPT, Gemini, and Claude in clinical and dermoscopic image analysis of basal cell carcinoma and its common mimickers: A comparative performance analysis.
Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Erasme hospital

Erasme Hospital

View all of Erasme's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital